Graham Capital Management’s Novo Nordisk NVO Stock Holding History

Graham Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Buy	+29,113	New	+$1.25M	0.03%	401
2025 Q3	–	Sell	-3,518	Closed	-$243K	–	1526
2025 Q2	$243K	Sell	3,518 -12,782	-78%	-$869K	﹤0.01%	1062
2025 Q1	$1.13M	Buy	+16,300	New	+$1.35M	0.02%	509
2024 Q4	–	Sell	-14,170	Closed	-$1.69M	–	1407
2024 Q3	$1.69M	Buy	+14,170	New	+$1.89M	0.03%	328
2024 Q1	–	Sell	-12,179	Closed	-$1.26M	–	1230
2023 Q4	$1.26M	Buy	+12,179	New	+$1.2M	0.03%	324
2014 Q4	–	Sell	-40,000	Closed	-$952K	–	166
2014 Q3	$952K	Buy	40,000 +29,000	+264%	+$667K	0.04%	124
2014 Q2	$254K	Buy	+11,000	New	+$243K	0.01%	148

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Graham Capital Management's NVO Position: Q2 2026 in Review

Graham Capital Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 29,113 shares worth $1.4M. The stake represents 0.03% of the portfolio and ranks #401 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in NVO as recently as Q2 2025.

Graham Capital Management first reported a position in NVO in Q2 2014 and has held it in 7 quarters since. The position peaked at $1.69M in Q3 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Graham Capital Management held 29,113 shares of Novo Nordisk worth $1.4M as of Q2 2026.
Novo Nordisk was a new Graham Capital Management position in Q2 2026.
Novo Nordisk made up 0.03% of Graham Capital Management's portfolio in Q2 2026, its #401 holding.
Graham Capital Management first reported a position in Novo Nordisk in Q2 2014 and has held it in 7 quarters since.
Graham Capital Management's Novo Nordisk position peaked at $1.69M in Q3 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.